T1	CHEM 67 82	micronutrientes
#1	AnnotatorNotes T1	C0282575; Micronutrients; Biologically Active Substance
T2	CHEM 83 94	vitamina D3
#2	AnnotatorNotes T2	C0008318; cholecalciferol; Organic Chemical · Pharmacologic Substance · Vitamin | C3265062; vitamin D3; Organic Chemical · Pharmacologic Substance · Vitamin
T3	CHEM 97 103	calcio
#3	AnnotatorNotes T3	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T4	DISO 120 148	diabéticos con hiperglucemia
#4	AnnotatorNotes T4	C2874070; diabetes mellitus type 1 with hyperglycemia; Disease or Syndrome
T5	DISO 199 212	hiperglucemia
#5	AnnotatorNotes T5	C0020456; Hyperglycemia; Disease or Syndrome
T6	DISO 241 258	diabetes mellitus
#6	AnnotatorNotes T6	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T7	DISO 260 262	DM
#7	AnnotatorNotes T7	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T8	DISO 428 456	diabéticos con hiperglucemia
#8	AnnotatorNotes T8	C2874070; diabetes mellitus type 1 with hyperglycemia; Disease or Syndrome
T9	CHEM 489 504	micronutrientes
#9	AnnotatorNotes T9	C0282575; Micronutrients; Biologically Active Substance
T10	PROC 534 548	ensayo clínico
#10	AnnotatorNotes T10	C0008976; Clinical Trials; Research Activity
T11	PROC 582 592	intervenir
#11	AnnotatorNotes T11	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T12	PROC 1386 1392	tratar
#12	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T13	PROC 628 639	intervenido
#13	AnnotatorNotes T13	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T14	PROC 666 673	ingreso
#14	AnnotatorNotes T14	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T15	CHEM 678 693	micronutrientes
#15	AnnotatorNotes T15	C0282575; Micronutrients; Biologically Active Substance
T16	CHEM 694 705	vitamina D3
#16	AnnotatorNotes T16	C0008318; cholecalciferol; Organic Chemical · Pharmacologic Substance · Vitamin | C3265062; vitamin D3; Organic Chemical · Pharmacologic Substance · Vitamin
T17	DISO 1322 1338	evento indeseado
#17	AnnotatorNotes T17	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T18	CHEM 756 762	calcio
#18	AnnotatorNotes T18	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T19	PROC 906 914	glucemia
#19	AnnotatorNotes T19	C0392201; Blood glucose measurement; Laboratory Procedure
T20	PROC 943 955	intervenidos
#20	AnnotatorNotes T20	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T21	DISO 1426 1443	evento indeseable
#21	AnnotatorNotes T21	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T22	PROC 1118 1129	intervenido
#22	AnnotatorNotes T22	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T23	PROC 45 59	administración
#23	AnnotatorNotes T23	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T24	PROC 1243 1255	intervención
#24	AnnotatorNotes T24	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T25	CHEM 1260 1271	vitamina D3
#25	AnnotatorNotes T25	C0008318; cholecalciferol; Organic Chemical · Pharmacologic Substance · Vitamin | C3265062; vitamin D3; Organic Chemical · Pharmacologic Substance · Vitamin
T26	CHEM 1274 1280	Calcio
#26	AnnotatorNotes T26	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T27	PROC 469 483	administración
#27	AnnotatorNotes T27	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T28	CHEM 1486 1501	micronutrientes
#28	AnnotatorNotes T28	C0282575; Micronutrients; Biologically Active Substance
T29	PROC 1539 1550	diagnóstico
#29	AnnotatorNotes T29	C0011900; Diagnosis; Diagnostic Procedure
T30	DISO 1561 1569	diabetes
#30	AnnotatorNotes T30	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T31	DISO 1784 1797	hiperglucemia
#31	AnnotatorNotes T31	C0020456; Hyperglycemia; Disease or Syndrome
T32	PROC 19 37	cifras de glucemia
#32	AnnotatorNotes T32	C0392201; Blood glucose measurement; Laboratory Procedure
T33	PROC 918 925	ingreso
#33	AnnotatorNotes T33	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T34	PROC 393 411	cifras de glucemia
#34	AnnotatorNotes T34	C0392201; Blood glucose measurement; Laboratory Procedure
T35	PROC 1067 1076	glucemias
#35	AnnotatorNotes T35	C0392201; Blood glucose measurement; Laboratory Procedure
T36	PROC 1340 1348	glucemia
#36	AnnotatorNotes T36	C0392201; Blood glucose measurement; Laboratory Procedure
T37	LIVB 107 116	pacientes
#37	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	Neg_cue 117 119	no
T39	LIVB 187 194	adultos
#38	AnnotatorNotes T39	C0001675; Adult; Age Group
T40	Neg_cue 213 216	sin
T41	LIVB 300 309	pacientes
#39	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	LIVB 415 424	pacientes
#40	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	Neg_cue 425 427	no
T44	LIVB 554 563	pacientes
#41	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	LIVB 604 617	grupo control
#42	AnnotatorNotes T45	C0009932; Control Groups; Group
T47	Dose 775 783	1.000 mg
T48	Frequency 784 797	cada 24 horas
T49	Duration 816 824	72 horas
T52	Duration 1029 1041	las 72 horas
T53	LIVB 1147 1160	grupo control
#43	AnnotatorNotes T53	C0009932; Control Groups; Group
T57	LIVB 1398 1407	pacientes
#44	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	LIVB 1516 1534	pacientes críticos
#45	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group + C0815272; critical population; Population Group
T60	Neg_cue 1535 1538	sin
T61	LIVB 1807 1816	pacientes
#46	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T64	Dose 718 753	1.000 unidades internacionales (UI)
T54	Spec_cue 1291 1297	riesgo
T56	LIVB 622 639	grupo intervenido
#47	AnnotatorNotes T56	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T59	LIVB 936 955	grupos intervenidos
#48	AnnotatorNotes T59	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T62	LIVB 574 592	grupo a intervenir
#49	AnnotatorNotes T62	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T65	LIVB 1112 1129	grupo intervenido
#50	AnnotatorNotes T65	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T46	LIVB 958 965	control
#51	AnnotatorNotes T46	C0009932; Control Groups; Group
T50	Neg_cue 839 841	no
T51	CONC 856 867	diferencias
#52	AnnotatorNotes T51	C1705241; Delta (difference); Quantitative Concept
A2	Population_data T39 Age
A3	Assertion T6 Negated
A7	Assertion T7 Negated
A4	Assertion T8 Negated
A5	Assertion T17 Speculated
A6	Assertion T30 Negated
A1	Assertion T4 Negated
A8	Status T6 History_of
A9	Status T7 History_of
A11	Assertion T29 Negated
A10	Status T30 History_of
R1	Used_for Arg1:T1 Arg2:T23
R2	Used_for Arg1:T2 Arg2:T23
R3	Combined_with Arg1:T2 Arg2:T3
R4	Experiences Arg1:T37 Arg2:T23
R5	Experiences Arg1:T37 Arg2:T32
R6	Experiences Arg1:T37 Arg2:T4
R7	Negation Arg1:T38 Arg2:T4
R8	Experiences Arg1:T39 Arg2:T4
R9	Experiences Arg1:T39 Arg2:T23
R10	Experiences Arg1:T39 Arg2:T32
R11	Negation Arg1:T40 Arg2:T6
R12	Negation Arg1:T40 Arg2:T7
R13	Experiences Arg1:T41 Arg2:T5
R14	Experiences Arg1:T41 Arg2:T7
R15	Experiences Arg1:T41 Arg2:T6
R16	Experiences Arg1:T42 Arg2:T34
R17	Negation Arg1:T43 Arg2:T8
R18	Used_for Arg1:T9 Arg2:T27
R19	Experiences Arg1:T42 Arg2:T8
R20	Experiences Arg1:T42 Arg2:T27
R21	Experiences Arg1:T62 Arg2:T11
R22	Experiences Arg1:T56 Arg2:T13
R23	Experiences Arg1:T56 Arg2:T14
R24	Used_for Arg1:T15 Arg2:T14
R25	Used_for Arg1:T16 Arg2:T14
R26	Experiences Arg1:T56 Arg2:T15
R27	Experiences Arg1:T56 Arg2:T16
R28	Has_Dose_or_Strength Arg1:T16 Arg2:T64
R29	Has_Dose_or_Strength Arg1:T18 Arg2:T47
R30	Combined_with Arg1:T16 Arg2:T18
R31	Has_Frequency Arg1:T18 Arg2:T48
R32	Has_Duration_or_Interval Arg1:T18 Arg2:T49
R33	Has_Frequency Arg1:T16 Arg2:T48
R34	Has_Duration_or_Interval Arg1:T16 Arg2:T49
A12	Assertion T51 Negated
R35	Negation Arg1:T50 Arg2:T51
R36	Overlap Arg1:T19 Arg2:T33
R37	Experiences Arg1:T59 Arg2:T20
R38	Experiences Arg1:T59 Arg2:T33
R39	Experiences Arg1:T59 Arg2:T19
R40	Experiences Arg1:T46 Arg2:T33
R41	Experiences Arg1:T46 Arg2:T19
R42	After Arg1:T35 Arg2:T52
R43	Experiences Arg1:T65 Arg2:T22
R44	Experiences Arg1:T65 Arg2:T35
R45	Experiences Arg1:T53 Arg2:T35
R46	Used_for Arg1:T25 Arg2:T24
R48	Speculation Arg1:T54 Arg2:T17
R49	Combined_with Arg1:T25 Arg2:T26
R47	Experiences Arg1:T57 Arg2:T12
R50	Experiences Arg1:T57 Arg2:T36
R51	Experiences Arg1:T57 Arg2:T21
R52	Experiences Arg1:T57 Arg2:T24
R53	Experiences Arg1:T57 Arg2:T17
R54	Experiences Arg1:T58 Arg2:T28
R56	Negation Arg1:T60 Arg2:T29
R57	Experiences Arg1:T58 Arg2:T30
R58	Experiences Arg1:T61 Arg2:T31
R61	Before Arg1:T33 Arg2:T35
R62	Before Arg1:T24 Arg2:T17
T55	Spec_cue 1728 1742	proporcionaría
T63	Quantifier_or_Qualifier 1743 1747	otra
A13	Assertion T63 Speculated
T66	CONC 1748 1759	alternativa
A14	Assertion T66 Speculated
#53	AnnotatorNotes T66	C1523987; Alternative; Qualitative Concept
R63	Overlap Arg1:T63 Arg2:T66	
R64	Speculation Arg1:T55 Arg2:T63	
R65	Speculation Arg1:T55 Arg2:T66	
T67	Quantifier_or_Qualifier 868 899	estadísticamente significativas
A15	Assertion T67 Negated
#54	AnnotatorNotes T67	C0237881; Statistical Significance; Quantitative Concept
R55	Negation Arg1:T50 Arg2:T67	
R59	Has_Quantifier_or_Qualifier Arg1:T51 Arg2:T67	
#55	AnnotatorNotes T63	C0205394; Other; Qualitative Concept
A16	Experiencer T37 Patient
A17	Experiencer T39 Patient
A18	Experiencer T41 Patient
A19	Experiencer T42 Patient
A20	Experiencer T44 Patient
A21	Experiencer T62 Patient
A22	Experiencer T45 Patient
A23	Experiencer T56 Patient
A24	Experiencer T59 Patient
A25	Experiencer T46 Patient
A26	Experiencer T65 Patient
A27	Experiencer T53 Patient
A28	Experiencer T57 Patient
A29	Experiencer T58 Patient
A30	Experiencer T61 Patient
